| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice. | J Psychopharmacol | 2011 | 1.16 |
| 2 | Cre/loxP-mediated chromosome engineering of the mouse genome. | Handb Exp Pharmacol | 2007 | 0.89 |
| 3 | Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model. | Adv Pharmacol Sci | 2011 | 0.85 |
| 4 | Genetic control of murine limb morphogenesis: relationships with human syndromes and evolutionary relevance. | Mol Cell Endocrinol | 1998 | 0.75 |